ImmunoGen
IMGN
#2140
Rank
ยฃ6.52 B
Marketcap
ยฃ23.35
Share price
0.00%
Change (1 day)
121.04%
Change (1 year)

Market capitalization of ImmunoGen (IMGN)

Last known market cap: ยฃ6.52 Billion

On April 12, 2024 ImmunoGen had a market cap of ยฃ6.52 Billion. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of ImmunoGen from 2001 to 2024

End of year Market Cap

Year Marketcap Change
2024ยฃ6.95 B11.6%
2023ยฃ6.22 B588.29%
2022ยฃ0.90 B-25.2%
2021ยฃ1.20 B31.32%
2020ยฃ0.92 B57.64%
2019ยฃ0.58 B3.46%
2018ยฃ0.56 B-9.93%
2017ยฃ0.62 B334.58%
2016ยฃ0.14 B-81.89%
2015ยฃ0.79 B136.32%
2014ยฃ0.33 B-55.71%
2013ยฃ0.76 B14.67%
2012ยฃ0.66 B16.62%
2011ยฃ0.56 B39.56%
2010ยฃ0.40 B46.59%
2009ยฃ0.27 B87.23%
2008ยฃ0.14 B65.89%
2007ยฃ89.61 M-16.85%
2006ยฃ0.10 B-11.81%
2005ยฃ0.12 B-34.99%
2004ยฃ0.18 B64.05%
2003ยฃ0.11 B40.45%
2002ยฃ81.59 M-82.06%
2001ยฃ0.45 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Seagen
SGEN
ยฃ32.26 B 394.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ130.98 B 1,907.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
ยฃ712.00 B 10,814.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ82.64 B 1,166.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
ยฃ385.83 B 5,814.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ112.36 B 1,622.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ193.96 B 2,873.35%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
ยฃ87.27 B 1,237.94%๐Ÿ‡ซ๐Ÿ‡ท France